The purpose of D-pro is to investigate the combined and separate effects of milk protein and vitamin D on bone health, growth, muscle function, body composition and cardiometabolic health in 6-8-year-old children.
The D-pro study investigates the effects of high or medium intakes of milk protein, and vitamin D supplements or placebo, in healthy 6-8 year-old Danish children. The study is a 2×2-factorial randomized controlled trial with 4 study arms. The subjects will be randomly allocated to receive yoghurt products with either high or medium protein content (300g/day, 6 days/week) and to receive tablets with either vitamin D (20 μg/day) or placebo for 24 weeks. Measurements and biological sampling will be performed at baseline and at the end of the intervention. The primary outcome will be bone mineral density (BMD). The investigators will also measure effects on children's muscle function, cardiometabolic health, body composition, growth and growth factors, nutrient status, immune defence and risk of acute respiratory tract infections, as well as appetite hormones. The investigators will also assess potential sex-specific effects and the potential modifying effect of genotype.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
200
High protein yoghurt which contains approx. 10 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.
One daily tablet containing 20 μg of vitamin D3, cholecalciferol.
Ordinary yoghurt containing approx. 3.3 g protein per 100 g. Participants will be asked to consume 300 g (=3 dl) 6 days a week.
Department of Nutrition, Exercise and Sports, University of Copenhagen
Frederiksberg, Denmark
Bone Mineral Density (BMD)
Measured by dual energy x-ray absorptiometry (DXA)
Time frame: 24 weeks
Bone Mineral Content (BMC)
by DXA
Time frame: 24 weeks
Fat mass index
by DXA
Time frame: 24 weeks
Fat free mass index
by DXA
Time frame: 24 weeks
Bone area
by DXA
Time frame: 24 weeks
Height
by stadiometer
Time frame: 24 weeks
Waist circumference
Time frame: 24 weeks
Insulin-like Growth Factor 1 (IGF-1)
by fasting blood sample
Time frame: 24 weeks
Insulin-like growth factor-binding protein 3 (IGFBP-3)
by fasting blood sample
Time frame: 24 weeks
Serum calcium
by fasting blood sample
Time frame: 24 weeks
Osteocalcin
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
by fasting blood sample
Time frame: 24 weeks
Parathyroid hormone (PTH)
by fasting blood sample
Time frame: 24 weeks
Bone-specific alkaline phosphatase
by fasting blood sample
Time frame: 24 weeks
C-terminal telopeptide of type 1 collagen in serum (s-CTX)
by fasting blood sample
Time frame: 24 weeks
Maximal leg press strength
Measured by isometric leg press
Time frame: 24 weeks
Maximal jumping height
Measured by squat jump with linear encoder
Time frame: 24 weeks
Maximal jumping length
Measured by standing long jump
Time frame: 24 weeks
Maximal grip strength
Measured by hand grip dynamometer
Time frame: 24 weeks
Muscle endurance
Measured by 30 sec. sit-to-stand
Time frame: 24 weeks
Blood pressure
Time frame: 24 weeks
Hemoglobin A1c (HbA1c)
by fasting blood sample
Time frame: 24 weeks
Glucose
by fasting blood sample
Time frame: 24 weeks
Insulin
by fasting blood sample
Time frame: 24 weeks
Total cholesterol
by fasting blood sample
Time frame: 24 weeks
High density lipoprotein cholesterol (HDL cholesterol)
by fasting blood sample
Time frame: 24 weeks
Low density lipoprotein cholesterol (LDL cholesterol)
by fasting blood sample
Time frame: 24 weeks
Triacylglycerol (TG)
by fasting blood sample
Time frame: 24 weeks